7454 Federal Register / Vol. 87, No. 27 / Wednesday, February 9, 2022 / Notices 

comment period for an additional 30 

days for ICR 3072–0070, though there 

are no errors with that previously 

published 60-day notice. 

DATES: Comments are due by March 11, 

2022. 

ADDRESSES: Submit comments for the 

proposed information collection 

requests to Lucille L. Marvin, Managing 

Director at email: omd@fmc.gov. Please 

refer to the assigned OMB control 

number on any correspondence 

submitted. The FMC will summarize 

any comments received in response to 

this notice in a subsequent notice and 

include them in its information 

collection submission to OMB for 

approval. 

FOR FURTHER INFORMATION CONTACT: 

Copies of the information collections 

and instructions, or copies of any 

comments received, may be obtained by 

contacting Lucille Marvin, Managing 

Director, at omd@fmc.gov or 202–523– 

5800. 

SUPPLEMENTARY INFORMATION: The 

Commission published the required 60- 

day notice for ICR 3072–0071 in the 

Federal Register on December 7, 2021, 

which provided the incorrect number of 

annual respondents and the incorrect 

total annual burden for this notice. See 

86 FR 69254 (December 7, 2021). The 

number of annual respondents was 

reported to be 194, and the total annual 

burden was reported to be 247 hours. 

The correct number of annual 

respondents is 2,129 and the correct 

total annual burden is 2,402 hours. 

Additionally, since publication of the 

60-day notice on December 7, 2021, the 

legal authority to conduct this collection 

was extended through 30 days after this 

publication. 

William Cody, 

Secretary. 

[FR Doc. 2022–02656 Filed 2–8–22; 8:45 am] 

BILLING CODE 6730–02–P 

FEDERAL MARITIME COMMISSION 

Notice of Agreements Filed 

The Commission hereby gives notice 

of filing of the following agreements 

under the Shipping Act of 1984. 

Interested parties may submit 

comments, relevant information, or 

documents regarding the agreements to 

the Secretary by email at Secretary@

fmc.gov, or by mail, Federal Maritime 

Commission, 800 North Capitol Street, 

Washington, DC 20573. Comments will 

be most helpful to the Commission if 

received within 12 days of the date this 

notice appears in the Federal Register, 

and the Commission requests that 

comments be submitted within 7 days 

on agreements that request expedited 

review. Copies of agreements are 

available through the Commission’s 

website (www.fmc.gov) or by contacting 

the Office of Agreements at (202)–523– 

5793 or tradeanalysis@fmc.gov. 

Agreement No.: 201349–002. 

Agreement Name: World Shipping 

Council Agreement. 

Parties: COSCO SHIPPING Lines Co., 

Ltd., Orient Overseas Container Line 

Ltd., and OOCL (Europe) Limited 

(acting as a single party); CMA CGM 

S.A., APL Co. Pte. Ltd., American 

President Lines, LLC and ANL 

Singapore Pte. Ltd. (acting as a single 

party); Crowley Caribbean Services, LLC 

and Crowley Latin America Services, 

LLC (acting as a single party); Evergreen 

Marine Corporation (Taiwan) Ltd.; 

Hapag-Lloyd AG; HMM Company 

Limited; Independent Container Line, 

Ltd.; Kawasaki Kisen Kaisha Ltd.; 

Maersk A/S and Hamburg Sud (acting as 

a single party); MSC Mediterranean 

Shipping Company SA; Mitsui O.S.K. 

Lines Ltd.; Nippon Yusen Kaisha; Ocean 

Network Express Pte. Ltd.; Wallenius 

Wilhelmsen Ocean AS; Wan Hai Lines 

Ltd. and Wan Hai Lines (Singapore) Pte. 

Ltd. (acting as a single party); Yang 

Ming Marine Transport Corp.; Zim 

Integrated Shipping Services, Ltd.; 

Matson Navigation Company, Inc.; and 

Swire Shipping Pte. Ltd. 

Filing Party: Robert Magovern; Cozen 

O’Connor. 

Synopsis: The amendment adds Swire 

Shipping Pte. Ltd. as a party to the 

Agreement. 

Proposed Effective Date: 3/19/2022. 

Location: https://www2.fmc.gov/ 

FMC.Agreements.Web/Public/ 

AgreementHistory/34503. 

Dated: February 4, 2022. 

William Cody, 

Secretary. 

[FR Doc. 2022–02742 Filed 2–8–22; 8:45 am] 

BILLING CODE 6730–02–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

intention of the Agency for Healthcare 

Research and Quality (AHRQ) to request 

that the Office of Management and 

Budget (OMB) approve the proposed 

information collection project 

‘‘TeamSTEPPS® Stakeholder Surveys 

for AHRQ’s ACTION III Diagnostic 

Safety Capacity Building Contract 

Task.’’ 

DATES: Comments on this notice must be 

received by April 11, 2022. 

ADDRESSES: Written comments should 

be submitted to: Doris Lefkowitz, 

Reports Clearance Officer, AHRQ, by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

Copies of the proposed collection plans, 

data collection instruments, and specific 

details on the estimated burden can be 

obtained from the AHRQ Reports 

Clearance Officer. 

FOR FURTHER INFORMATION CONTACT: 

Doris Lefkowitz, AHRQ Reports 

Clearance Officer, (301) 427–1477, or by 

email at doris.lefkowitz@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Proposed Project 

TeamSTEPPS® Stakeholder Surveys for 

AHRQ’s ACTION III Diagnostic Safety 

Capacity Building Contract Task 3 

AHRQ awarded a contract to the 

MedStar Health Research Institute 

(MHRI) in 2019 and received OMB fast 

track clearance (OMB control number 

0935–0179, expiration date of 11/30/23), 

to provide program support and 

expertise related to improving 

diagnostic safety and quality across five 

distinct contract tasks. Task 3 of the 

contract is to develop, pilot test and 

promote a TeamSTEPPS® Course to 

improve communication among 

providers related to diagnosis. 

TeamSTEPPS® to Improve Diagnosis 

provides communication strategies, 

including methods to improve intraprofessional communication and 

communication during the referral 

process and to practice mutual support 

and situation monitoring during the 

diagnostic process. TeamSTEPPS® to 

Improve Diagnosis includes an 

educational module for leaders on 

strategies to facilitate improved 

communication with and among 

providers related to diagnosis. This 

module also includes a Team 

Assessment Tool for Improving 

Diagnosis (the ‘‘Team Assessment 

Tool’’). 

The Team Assessment Tool is an 

instrument developed as a method of 

self-assessment, with the goal of helping 

teams reflect on their current diagnostic 

and teamwork practices. In addition, it 

orients them to the repertoire of tools 

available within the TeamSTEPPS for 

Improving Diagnosis course that are 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 27 / Wednesday, February 9, 2022 / Notices 7455 

available to support improvement 

efforts. The Team Assessment Tool asks 

participants to complete self-assessment 

ratings as a mechanism to identify 

strengths and opportunities for 

improvement in unit-based teamwork. 

The unit level aggregate results of the 

assessments help unit leaders identify 

priorities for training via use of course 

modules and specific interventions with 

their diagnostic improvement teams. 

AHRQ would like to further develop 

this Team Assessment Tool into a 

measurement instrument, expanding on 

its intended use as an educational 

activity and formative assessment. The 

opportunity to provide evidence (via 

publication in peer reviewed journals) 

that the tool is both valid and reliable 

will strengthen its acceptance in the 

care delivery community and provide a 

scientifically sound method for teams to 

assess changes in performance overtime. 

The Team Assessment Tool requires 

psychometric testing in order to ensure 

validity and reliability. 

Psychometrics is the construction and 

validation of measurement instruments 

and assessing if these instruments are 

reliable (have consistency in 

measurement) and valid (have accuracy 

in measurement). Reliability and 

validity indicate how well a method, 

technique, test, or instrument is truly 

measuring what it intends to measure. 

The contractor has conducted 

precursor psychometric testing on the 

Team Assessment Tool, which included 

the following: (1) Item wording and 

scale refinement, (2) Project Team 

Subject Matter Expert content review, 

(3) Non-Project Team Subject Matter 

Expert review, (4) End-user feedback, 

and (5) Instrument refinement. This 

work puts the reliability and validity of 

the indicators of the instrument at an 

optimal starting point for full 

psychometric testing. 

Full psychometric testing of this 

instrument means the scaling must be 

evaluated extensively, which will 

require a sample of at least 359 

individual care team members 

(physicians, nurses, ancillary staff, etc.,) 

from diverse clinical settings to 

participate in a 15-minute, anonymous, 

online survey distributed via a shared 

electronic survey link. Individual care 

team members will be recruited from 

across 9 health systems or care settings. 

The survey will ask participants to read 

through and complete the questions; 

participants will not be privy to the 

results of the survey. 

The contractor will examine this 

sample of results via analyses to 

determine the stability of the instrument 

and its indicators, ensuring parallel 

measurements, homogeneity among 

indicators, concurrent, convergent, and 

discriminant validity, latent constructs 

of the tool, the extent to which measures 

of the same concept correlate and 

diverge, and the degree of that 

correlation in evaluating the 

instrument’s ability to discriminate 

between different groups with various 

levels and familiarity with safety 

culture. It is important to note the 

responses on the surveys are not being 

evaluated, but rather the consistency 

with which the questions are answered 

is being evaluated (i.e., determining 

whether the questions are being 

interpreted the same by all the users), 

despite diverse healthcare settings and 

varying levels of experience and 

familiarity with TeamSTEPPS. The 

combination of these psychometric 

methods will allow for internal and 

external validity and reliability to be 

assessed, to create a psychometrically 

sound instrument vetted for potential 

widespread adoption. 

The Team Assessment Tool 

instrument will undergo remote 

usability testing of a survey to refine 

questions. To execute this task, the 

contractor has assembled an 

interprofessional team to execute any or 

all of the following methods for 

generating reliability and validity 

evidence that would be applicable to 

this specific tool: (1) Parallel forms 

reliability, (2) internal consistency 

reliability, (3) inter-rater reliability, (4) 

content validity, and (5) construct 

validity, using a multitrait-multimethod 

matrix and/or known groups testing. 

This information collection has the 

following goal: 

1. To determine the stability of the 

Team Assessment Tool instrument and 

its indicators in improving 

communication to reduce diagnostic 

errors, by quantitatively examining the 

correlation among responses of each 

indicator. 

This study is being conducted by 

AHRQ through its contractor, MedStar 

Health Research Institute, pursuant to 

AHRQ’s statutory authority to conduct 

and support research on health care and 

on systems for the delivery of such care, 

including activities with respect to the 

quality, effectiveness, efficiency, 

appropriateness and vale of healthcare 

services and with respect to quality 

measurement and improvement. 42 

U.S.C 299a(a)(1) and (2). 

Method of Collection 

To achieve the goal of this project the 

following information collection 

instruments will be completed using 

individual surveys: 

(1) Setting Demographics Survey: 

Prior to testing of the instrument, each 

health system will take a brief survey to 

describe the characteristics of the sites 

engaged in pilot testing (e.g., size, 

diagnostic team member role diversity, 

and familiarity with patient safety and 

quality improvement activities). 

(2) TeamSTEPPS® Team Assessment 

Tool for Improving Diagnosis: This is 

collected from individual survey 

respondents, who are diverse staff 

members in a diagnostic team. The 

consistency with which the questions 

are interpreted and answered among 

respondents will be evaluated to 

determine the stability among indicators 

on the instrument. 

AHRQ will use the information 

collected through this Information 

Collection Request to assess and 

enhance the feasibility of adopting a 

course to improve communication 

among providers related to diagnosis. 

AHRQs’ ability to publicly share a Team 

Assessment Tool that has been 

scientifically validated is expected to be 

of great interest to the health care 

community and important in helping 

organizations prioritize improvement 

efforts. 

Estimated Annual Respondent Burden 

EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Hours 

per response 

Total 

burden hours 

Setting Demographics Survey ......................................................................... 9 1 0.25 2.25 

TeamSTEPPS® Team Assessment Tool for Improving Diagnosis ................. 350 1 0.25 87.5 

Total .......................................................................................................... 359 ........................ ........................ 89.75 


lotter on DSK11XQN23PROD with NOTICES1
7456 Federal Register / Vol. 87, No. 27 / Wednesday, February 9, 2022 / Notices 

EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN

Form name Number of 

respondents 

Total 

burden hours 

Average 

hourly 

wage rate 

Total 

cost burden 

Setting Demographics Survey ......................................................................... 9 2.25 a $57.12 $128.52 

TeamSTEPPS® Team Assessment Tool for Improving Diagnosis ................. 265 66.25 b 103.06 6,827.73 

TeamSTEPPS® Team Assessment Tool for Improving Diagnosis ................. 85 21.25 c 15.50 329.38 

Total .......................................................................................................... 359 89.75 ........................ $7,285.63 

aBased on the mean wages for Medical and Health Services Managers (Code 11–9111). bBased on the mean wages for Family Medicine Physicians (Code 29–1215). cBased on the mean wages for HC Support Occupations (Code 31–0000). 

Occupational Employment Statistics, May 2020 National Occupational Employment and Wage Estimates United States, U.S. Department of 

Labor, Bureau of Labor Statistics. https://www.bls.gov/oes/current/oes_nat.htm#b29-0000. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, 44 U.S.C. 3501–3520, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ’s health care research and health 

care information dissemination 

functions, including whether the 

information will have practical utility; 

(b) the accuracy of AHRQ’s estimate of 

burden (including hours and costs) of 

the proposed collection(s) of 

information; (c) ways to enhance the 

quality, utility and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: February 4, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–02734 Filed 2–8–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—SIP22–002, 

Electronic Health Record Study to Examine 

Factors and Diagnostic Pathways that 

Facilitate Early Ovarian Cancer Diagnoses. 

Date: April 27, 2022. 

Time: 11:00 a.m.–6:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman, Ph.D., Scientific Review Officer, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 4770 

Buford Highway, Mailstop S107–B, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

Email: JRaman@cdc.gov. 

The Director, Strategic Business Initiatives 

Unit, Office of the Chief Operating Officer, 

Centers for Disease Control and Prevention, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–02647 Filed 2–8–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—SIP22–003, 

Improving and evaluating measures to 

identify tics and tic disorders including 

Tourette syndrome in children in 

epidemiologic studies and clinical settings. 

Date: April 28, 2022. 

Time: 11:00 a.m.–6:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman, Ph.D., Scientific Review Officer, 

National Center for Chronic Disease 

Prevention and Health Promotion, CDC, 4770 

Buford Highway, Mailstop S107–B, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

Email: JRaman@cdc.gov. 

The Director, Strategic Business Initiatives 

Unit, Office of the Chief Operating Officer, 

Centers for Disease Control and Prevention, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 


lotter on DSK11XQN23PROD with NOTICES1